Intensive glucose control improves kidney outcomes in patients with type 2 diabetes.
The effect of intensive glucose control on major kidney outcomes in type 2 diabetes remains unclear. To study this, the ADVANCE trial randomly assigned 11,140 participants to an intensive glucose-lowering strategy (hemoglobin A1c target 6.5% or less) or standard glucose control. Treatment effects on...
मुख्य लेखकों: | Perkovic, V, Heerspink, H, Chalmers, J, Woodward, M, Jun, M, Li, Q, MacMahon, S, Cooper, M, Hamet, P, Marre, M, Mogensen, C, Poulter, N, Mancia, G, Cass, A, Patel, A, Zoungas, S |
---|---|
स्वरूप: | Journal article |
भाषा: | English |
प्रकाशित: |
2013
|
समान संसाधन
-
Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial.
द्वारा: Zoungas, S, और अन्य
प्रकाशित: (2009) -
Intensive glucose lowering and the risk of vascular events and premature death in patients with decreased kidney function: the ADVANCE trial
द्वारा: Ohkuma, T, और अन्य
प्रकाशित: (2019) -
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
द्वारा: Patel, A, और अन्य
प्रकाशित: (2008) -
Lowering blood pressure reduces renal events in type 2 diabetes.
द्वारा: de Galan, B, और अन्य
प्रकाशित: (2009) -
Estimating individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes
द्वारा: Woodward, M, और अन्य
प्रकाशित: (2016)